InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Dulac Edward J III, Chief Financial Officer. Director active across 2 companies, notably Fate Therapeutics INC. Aggregated, 22 disclosures have been recorded. Breakdown: 0 buy · 15 sells. Total volume traded: €783k. Activity tracked since 19 August 2021. The latest transaction was disclosed on 22 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Dulac Edward J III
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
8,111 shares@ US$11.250.0059% mcap27.3% of flowCommon StockSEC:0001193125-26-316279:0
4,677 shares@ US$18.000.0053% mcap100.0% of flowCommon StockSEC:0001821530-26-000002:0
61,280 shares0Common StockSEC:0001193125-26-088254:0
6,379 shares@ US$9.2123.6% of flowCommon StockSEC:0001193125-26-006275:0
7,462 shares@ US$14.0254.7% of flowCommon StockSEC:0000950170-25-098774:0
47,200 shares0Common StockSEC:0000950170-25-032192:0
66,324 shares0Common StockSEC:0000950170-24-086061:0
2,447 shares@ US$7.770.7% of flowCommon StockSEC:0000950170-24-025992:0
1,849 shares@ US$5.000.3% of flowCommon StockSEC:0000950170-24-008803:0
7,028 shares@ US$4.371.1% of flowCommon StockSEC:0000950170-24-003647:0
5,182 shares@ US$3.660.6% of flowCommon StockSEC:0000950170-24-000874:0
1,585 shares@ US$3.500.2% of flowCommon StockSEC:0001209191-23-059103:0
4,718 shares@ US$2.800.5% of flowCommon StockSEC:0001209191-23-046691:0
5,182 shares@ US$4.830.9% of flowCommon StockSEC:0001209191-23-041607:0
7,331 shares@ US$5.241.3% of flowCommon StockSEC:0001209191-23-002975:0
4,703 shares@ US$29.755.2% of flowCommon StockSEC:0001209191-22-046929:0
33,302 shares0Common StockSEC:0000899243-22-003443:0
1,380 shares@ US$48.254.0% of flowCommon StockSEC:0001209191-22-003168:0
14,437 shares@ US$35.5231.0% of flowCommon StockSEC:0001209191-21-070768:0
59,540 shares0Common StockSEC:0001209191-21-066159:0
17,325 shares@ US$35.5235.7% of flowCommon StockSEC:0001209191-21-058176:0
1,937 shares@ US$87.909.9% of flowCommon StockSEC:0001209191-21-052742:0
22 of 22 declarations
About Dulac Edward J III
Dulac Edward J III is Directeur Financier. He has 21 filings in total, and in the recent filings available, all are sales, for a total of EUR 703367 between 2021-08-20 and 2026-07-06. His listed companies are Fate Therapeutics INC and Intellia Therapeutics, Inc.
